Bisoprolol Fumarate + Hydrochlorothiazide

Generic Details

Generic Name

Bisoprolol-Fumarate-Hydrochlorothiazide

Other Names

  • Bisoprolol HCTZ

Drug Class

  • Beta-blocker with thiazide diuretic

Chemical Formula

C18H31NO4.C7H8ClN3O4S2

Molecular Weight

681.68 g/mol

Mechanism of Action

  • Bisoprolol reduces heart rate and blood pressure by blocking beta receptors. Hydrochlorothiazide promotes diuresis by inhibiting sodium reabsorption.

Indications

  • Hypertension
  • Congestive heart failure

Common Dosage Forms

  • Tablet

Typical Dosage

  • 5mg/6.25mg to 10mg/6.25mg once daily

Pediatric Dosage

  • Not established

Geriatric Dosage

  • Dosage adjustments may be required

Side Effects

  • Dizziness
  • Fatigue
  • Hypotension
  • Increased urination
  • Electrolyte imbalances

Contraindications

  • Bradycardia
  • Severe hepatic impairment
  • Severe renal impairment

Pregnancy Category

  • C - Bisoprolol
  • C - Hydrochlorothiazide

Lactation Safety

  • Limited data available, caution advised

Drug Interactions

  • NSAIDs
  • Lithium
  • Digitalis glycosides

Overdose Symptoms

  • Severe hypotension
  • Bradycardia
  • Electrolyte abnormalities

Antidote for Overdose

  • Intravenous fluids
  • Atropine for bradycardia

Storage Conditions

  • Store at room temperature away from moisture and heat

Pharmacokinetics

  • Absorption: Well absorbed orally
  • Distribution: Bisoprolol: Widely distributed, Hydrochlorothiazide: Crosses the placenta and enters breast milk
  • Metabolism: Bisoprolol: Hepatic (CYP2D6), Hydrochlorothiazide: Minimal metabolism
  • Excretion: Renal

Precautions

  • Caution in patients with asthma or COPD due to beta-blocker component
  • Monitor electrolytes periodically

Warnings

  • May cause fetal harm if used during pregnancy
  • Avoid abrupt withdrawal to prevent rebound hypertension

Others

  • Combination therapy to address both hypertension and heart failure